The Latest Breaking News from FDA

Trump ally Robert F. Kennedy Jr. has expressed skepticism about vaccines and vowed to restructure federal health agencies.

Officials clarified that the proposed ban is not related to the safety of oral phenylephrine and companies may continue selling products containing the ingredient until the order is finalized.

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

The world's richest person could get a lot of help with contracts and regulatory headaches during the Trump administration.

The Food and Drug Administration has seized more than 94,000 illegal Chinese products from dozens of shops in Bangkok over the past three months.

Kennedy has made controversial remarks about what he’d do if put in charge of US health care

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for portfolio protection. Thus, quality defensive stocks Johnson & Johnson (JNJ), Pfizer (PFE), and Genie Energy (GNE) could be ideal portfolio additions as market volatility rises. Continue reading.

Robert F. Kennedy Jr. stated in an interview that he believes entire departments of the Food and Drug Administration (FDA) are unnecessary and should be dissolved.

Biotech stocks are surging as groundbreaking neuroscience and gene therapy innovations take center stage. Amid this backdrop, investors might consider adding fundamentally strong biotech stocks like Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and Gilead Sciences (GILD) to their portfolio for an impactful investment. Continue reading….